The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer

Nucleic Acids Research

Volumn 43, Issue 1, 2015, Pages 196-207

  Wade, Mark A ^a   Jones, Dominic ^a   Wilson, Laura ^a   Stockley, Jacqueline ^b   Coffey, Kelly ^a   Robson, Craig N ^a   Gaughan, Luke ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HISTONE DEMETHYLASE; KDM3A PROTEIN, HUMAN;

BREAST TUMOR; CELL PROLIFERATION; DNA RESPONSIVE ELEMENT; DRUG RESISTANCE; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MCF-7 CELLS; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION;

EID: 84944897102     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku1298     Document Type: Article

References (58)

1. Howard,J.H. and Bland,K.I. (2012) Current management and treatment strategies for breast cancer. Curr. Opin. Obstet. Gynecol., 24, 44-48.
2. Johnston,S.R., Saccani-Jotti,G., Smith,I.E., Salter,J., Newby,J., Coppen,M., Ebbs,S.R. and Dowsett,M. (1995) Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res., 55, 3331-3338.
3. Green,K.A. and Carroll,J.S. (2007) Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat. Rev. Cancer, 7, 713-722.
4. Lupien,M. and Brown,M. (2009) Cistromics of hormone-dependent cancer. Endocr. Cancer, 16, 381-389.
5. Anzick,S.L., Kononen,J., Walker,R.L., Azorsa,D.O., Tanner,M.M., Guan,X.Y., Sauter,G., Kallioniemi,O.P., Trent,J.M. and Meltzer,P.S. (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science, 277, 965-968.
6. Lavinsky,R.M., Jepsen,K., Heinzel,T., Torchia,J., Mullen,T.M., Schiff,R., Del-Rio,A.L., Ricote,M., Ngo,S., Gemsch,J. et al. (1998) Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. U.S.A., 95, 2920-2925.
7. Kurebayashi,J., Otsuki,T., Kunisue,H., Tanaka,K., Yamamoto,S. and Sonoo,H. (2000) Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Clin. Cancer Res., 6, 512-518.
8. Elsheikh,S.E., Green,A.R., Rakha,E.A., Powe,D.G., Ahmed,R.A., Collins,H.M., Soria,D., Garibaldi,J.M., Paish,C.E., Ammar,A.A. et al. (2009) Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res., 69, 3802-3809.
9. Seligson,D.B., Horvath,S., Shi,T., Yu,H., Tze,S., Grunstein,M. and Kurdistani,S.K. (2005) Global histone modification patterns predict risk of prostate cancer recurrence. Nature, 435, 1262-1266.
10. Ng,S.S., Yue,W.W., Oppermann,U. and Klose,R.J. (2009) Dynamic protein methylation in chromatin biology. Cell. Mol. Life Sci.: CMLS, 66, 407-422.
11. Shi,Y. and Whetstine,J.R. (2007) Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell, 25, 1-14.
12. Cloos,P.A., Christensen,J., Agger,K. and Helin,K. (2008) Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev., 22, 1115-1140.
13. Agger,K., Christensen,J., Cloos,P.A. and Helin,K. (2008) The emerging functions of histone demethylases. Curr. Opin. Genet. Dev., 18, 159-168.
14. Shi,Y.G. and Tsukada,Y. (2013) The discovery of histone demethylases. Cold Spring Harbor Perspect. Biol., 5.
15. Kleer,C.G., Cao,Q., Varambally,S., Shen,R., Ota,I., Tomlins,S.A., Ghosh,D., Sewalt,R.G., Otte,A.P., Hayes,D.F. et al. (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. U.S.A., 100, 11606-11611.
16. Shi,B., Liang,J., Yang,X., Wang,Y., Zhao,Y., Wu,H., Sun,L., Zhang,Y., Chen,Y., Li,R. et al. (2007) Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol. Cell. Biol., 27, 5105-5119.
17. Lim,S., Janzer,A., Becker,A., Zimmer,A., Schule,R., Buettner,R. and Kirfel,J. (2010) Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis, 31, 512-520.
18. Garcia-Bassets,I., Kwon,Y.S., Telese,F., Prefontaine,G.G., Hutt,K.R., Cheng,C.S., Ju,B.G., Ohgi,K.A., Wang,J., Escoubet-Lozach,L. et al. (2007) Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell, 128, 505-518.
19. Gaughan,L., Stockley,J., Coffey,K., O'Neill,D., Jones,D.L., Wade,M., Wright,J., Moore,M., Tse,S., Rogerson,L. et al. (2013) KDM4B is a master regulator of the estrogen receptor signalling cascade. Nucleic Acids Res., 41, 6892-6904.
20. Kawazu,M., Saso,K., Tong,K.I., McQuire,T., Goto,K., Son,D.O., Wakeham,A.,Miyagishi,M., Mak,T.W. and Okada,H. (2011) Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One, 6, e17830.
21. Luo,W., Chang,R., Zhong,J., Pandey,A. and Semenza,G.L. (2012) Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression. Proc. Natl. Acad.Sci. U.S.A., 109, E3367-3376.
22. Shi,L., Sun,L., Li,Q., Liang,J., Yu,W., Yi,X., Yang,X., Li,Y., Han,X., Zhang,Y. et al. (2011) Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc. Natl. Acad. Sci. U.S.A., 108, 7541-7546.
23. Yamane,K., Toumazou,C., Tsukada,Y., Erdjument-Bromage,H., Tempst,P., Wong,J. and Zhang,Y. (2006) JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell, 125, 483-495.
24. Brauchle,M., Yao,Z., Arora,R., Thigale,S., Clay,I., Inverardi,B., Fletcher,J., Taslimi,P., Acker,M.G., Gerrits,B. et al. (2013) Protein complex interactor analysis and differential activity of KDM3 subfamily members towards H3K9 methylation. PLoS One, 8, e60549.
25. Cho,H.S., Toyokawa,G., Daigo,Y., Hayami,S., Masuda,K., Ikawa,N., Yamane,Y., Maejima,K., Tsunoda,T., Field,H.I. et al. (2012) The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene. Int. J. Cancer, 131, E179-189.
26. Beyer,S., Kristensen,M.M., Jensen,K.S., Johansen,J.V. and Staller,P. (2008) The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem., 283, 36542-36552.
27. Krieg,A.J., Rankin,E.B., Chan,D., Razorenova,O., Fernandez,S. and Giaccia,A.J. (2010) Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol. Cell. Biol., 30, 344-353.
28. Park,S.J., Kim,J.G., Son,T.G., Yi,J.M., Kim,N.D., Yang,K. and Heo,K. (2013) The histone demethylase JMJD1A regulates adrenomedullin-mediated cell proliferation in hepatocellular carcinoma under hypoxia. Biochem. Biophys. Res. Commun., 434, 722-727.
29. Gaughan,L., Logan,I.R., Neal,D.E. and Robson,C.N. (2005) Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res., 33, 13-26.
30. Gaughan,L., Logan,I.R., Cook,S., Neal,D.E. and Robson,C.N. (2002) Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. J. Biol. Chem., 277, 25904-25913.
31. Gentleman,R.C., Carey,V.J., Bates,D.M., Bolstad,B., Dettling,M., Dudoit,S., Ellis,B., Gautier,L., Ge,Y., Gentry,J. et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol., 5, R80.
32. Huber,W., von Heydebreck,A., Sultmann,H., Poustka,A. and Vingron,M. (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics, 18(Suppl. 1), S96-S104.
33. Smyth,G.K. (2005) Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor. Springer-Verlag, New York, pp. 397-420.
34. Benjamini,Y. and Hochberg,Y. (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. J. R. Stat. Soc. B Met., 57, 289-300.
35. Huang da,W., Sherman,B.T. and Lempicki,R.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
36. Huang da,W., Sherman,B.T. and Lempicki,R.A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res., 37, 1-13.
37. Malinen,M., Jaaskelainen,T., Pelkonen,M., Heikkinen,S., Vaisanen,S., Kosma,V.M., Nieminen,K., Mannermaa,A. and Palvimo,J.J. (2013) Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors. Mol. Cell. Endocrinol., 365, 270-276.
38. Merkel,A.L., Meggers,E. and Ocker,M. (2012) PIM1 kinase as a target for cancer therapy. Expert Opin. Invest. Drugs, 21, 425-436.
39. Sheng,S., Barnett,D.H. and Katzenellenbogen,B.S. (2008) Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells. Mol. Cell. Endocrinol., 296, 1-9.
40. Semenza,G.L. (2012) Molecular mechanisms mediating metastasis of hypoxic breast cancer cells. Trends Mol. Med., 18, 534-543.
41. Wong,C.C., Zhang,H., Gilkes,D.M., Chen,J., Wei,H., Chaturvedi,P., Hubbi,M.E. and Semenza,G.L. (2012) Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis. J. Mol. Med., 90, 803-815.
42. Kirschmann,D.A., Seftor,E.A., Fong,S.F., Nieva,D.R., Sullivan,C.M., Edwards,E.M., Sommer,P., Csiszar,K. and Hendrix,M.J. (2002) A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res., 62, 4478-4483.
43. Wang,L., Chang,J., Varghese,D., Dellinger,M., Kumar,S., Best,A.M., Ruiz,J., Bruick,R., Pena-Llopis,S., Xu,J. et al. (2013) A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth. Nat. Commun., 4, 2035.
44. Chu,C.H., Wang,L.Y., Hsu,K.C., Chen,C.C., Cheng,H.H., Wang,S.M., Wu,C.M., Chen,T.J., Li,L.T., Liu,R. et al. (2014) KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor. J. Med. Chem., 57, 5975-5985.
45. Limer,J.L., Parkes,A.T. and Speirs,V. (2006) Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitro. Int. J. Cancer, 119, 515-521.
46. Mahajan,K., Lawrence,H.R., Lawrence,N.J. and Mahajan,N.P. (2014) ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1. J. Biol. Chem., 289, 28179-28191.
47. Wellmann,S., Bettkober,M., Zelmer,A., Seeger,K., Faigle,M., Eltzschig,H.K. and Buhrer,C. (2008) Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem. Biophys. Res. Commun., 372, 892-897.
48. Cho,J., Bahn,J.J., Park,M., Ahn,W. and Lee,Y.J. (2006) Hypoxic activation of unoccupied estrogen-receptor-alpha is mediated by hypoxia-inducible factor-1 alpha. J. Steroid Biochem. Mol. Biol., 100, 18-23.
49. Yi,J.M., Kwon,H.Y., Cho,J.Y. and Lee,Y.J. (2009) Estrogen and hypoxia regulate estrogen receptor alpha in a synergistic manner. Biochem. Biophys. Res. Commun., 378, 842-846.
50. Ryu,K., Park,C. and Lee,Y. (2011) Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells. Biochem. Biophys. Res. Commun., 407, 831-836.
51. George,A.L., Rajoria,S., Suriano,R., Mittleman,A. and Tiwari,R.K. (2012) Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence. Mol. Cancer, 11, 80.
52. Tee,A.E., Ling,D., Nelson,C., Atmadibrata,B., Dinger,M.E., Xu,N., Mizukami,T., Liu,P.Y., Liu,B., Cheung,B. et al. (2014) The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget, 5, 1793-1804.
53. Metivier,R., Penot,G., Hubner,M.R., Reid,G., Brand,H., Kos,M. and Gannon,F. (2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell, 115, 751-763.
54. Hanstein,B., Eckner,R., DiRenzo,J., Halachmi,S., Liu,H., Searcy,B., Kurokawa,R. and Brown,M. (1996) p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. U.S.A., 93, 11540-11545.
55. Okada,Y., Scott,G., Ray,M.K., Mishina,Y. and Zhang,Y. (2007) Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis. Nature, 450, 119-123.
56. Inagaki,T., Tachibana,M., Magoori,K., Kudo,H., Tanaka,T., Okamura,M., Naito,M., Kodama,T., Shinkai,Y. and Sakai,J. (2009) Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice. Genes Cells, 14, 991-1001.
57. Liu,Z., Zhou,S., Liao,L., Chen,X., Meistrich,M. and Xu,J. (2010) Jmjd1a demethylase-regulated histone modification is essential for cAMP-response element modulator-regulated gene expression and spermatogenesis. J. Biol. Chem., 285, 2758-2770.
58. Magnani,L., Stoeck,A., Zhang,X., Lanczky,A., Mirabella,A.C., Wang,T.L., Gyorffy,B. and Lupien,M. (2013) Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer. Proc. Natl. Acad. Sci. U.S.A., 110, E1490-1499.